Research efforts are focused on development of heavy ion micro surgery for upgrading cancer therapy and expanding therapeutic indication. For its purpose, researches and developments are conducted on heavy ion beam irradiation techniques using the heavy ion therapy facilities only in the national universities.
In addition, clinical researches on combination of heavy ion therapy and molecular target drugs etc. are promoted to overcome resistant cancers to any therapeutic modalities.
This research program aims at development and clinical application of novel theranostic probes based on radioisotope-labeled nanoparticles that can provide both diagnostic imaging with high accuracy and sensitivity, and minimum invasive cancer therapy.
This research program is focused on development of omics-based medicine that can discover drugs and establish a personalized medicine for life style disease, especially for cancer.
Based on accumulated achievements through the COE and Global COE programs at Gunma University, this research program aims to investigate the mechanism of signal transduction in the field of endocrinology, metabolism, and development to elucidate the etiology and pathogenesis of life-style diseases and to search for their molecular targets.
We explore the pathophysiological mechanisms underlying the metabolic syndrome and cardiovascular disease that are highly prevalent and increasing worldwide. Our approach is to uncover the regulatory mechanisms of endocrine function and energy metabolisms and to develop the novel therapeutic strategies for this disorder.
This research program aims to study the homeostatic and degenerative signaling of the nervous system, and consequently to develop novel therapies against intractable neurological disorders.